Skip to main content

and
Your search also matched 1 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Early to Long-Term Alterations of CNS Barriers After Traumatic Brain Injury: Considerations for Drug Development

Include preview-only content
  1. Article

    Open Access

    Safety, Tolerability, Pharmacokinetics and Initial Pharmacodynamics of a Subcommissural Organ-Spondin-Derived Peptide: A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose First-in-Human Study

    This randomized, double-blind, placebo-controlled study in healthy volunteers assessed the safety, tolerability, and pharmacokinetics of single ascending doses of intravenously administered NX210—a linear pept...

    Valérie Bourdès, Peter Dogterom, André Aleman, Pierre Parmantier in Neurology and Therapy (2022)

  2. Article

    Open Access

    Lack of collagen XV is protective after ischemic stroke in mice

    Collagens are key structural components of basement membranes, providing a scaffold for other components or adhering cells. Collagens and collagen-derived active fragments contribute to biological activities s...

    Hiramani Dhungana, Mikko T Huuskonen, Taina Pihlajaniemi in Cell Death & Disease (2018)

  3. Article

    Open Access

    Sulfosuccinimidyl oleate sodium is neuroprotective and alleviates stroke-induced neuroinflammation

    Ischemic stroke is one of the main causes of death and disability worldwide. It is caused by the cessation of cerebral blood flow resulting in the insufficient delivery of glucose and oxygen to the neural tiss...

    Hiramani Dhungana, Mikko T. Huuskonen, Merja Jaronen in Journal of Neuroinflammation (2017)

  4. Article

    Open Access

    Bexarotene targets autophagy and is protective against thromboembolic stroke in aged mice with tauopathy

    Stroke is a highly debilitating, often fatal disorder for which current therapies are suitable for only a minor fraction of patients. Discovery of novel, effective therapies is hampered by the fact that advanc...

    Mikko T. Huuskonen, Sanna Loppi, Hiramani Dhungana in Scientific Reports (2016)

  5. Article

    Open Access

    Erratum to: ADAMTS-4 promotes neurodegeneration in a mouse model of amyotrophic lateral sclerosis

    Sighild Lemarchant, Yuriy Pomeshchik, Iurii Kidin in Molecular Neurodegeneration (2016)

  6. Article

    Open Access

    ADAMTS-4 promotes neurodegeneration in a mouse model of amyotrophic lateral sclerosis

    A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) proteoglycanases are specialized in the degradation of chondroitin sulfate proteoglycans and participate in mechanisms mediating neuropla...

    Sighild Lemarchant, Yuriy Pomeshchik, Iurii Kidin in Molecular Neurodegeneration (2016)

  7. Article

    Open Access

    ADAMTS proteoglycanases in the physiological and pathological central nervous system

    ADAMTS-1, -4, -5 and -9 belong to ‘a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)’ family and more precisely to the proteoglycanases subgroup based on their common ability to degrade c...

    Sighild Lemarchant, Mathilde Pruvost, Joan Montaner in Journal of Neuroinflammation (2013)